SG10202000307VA - Materials and methods relating to stabilised polymeric silicate compositions - Google Patents
Materials and methods relating to stabilised polymeric silicate compositionsInfo
- Publication number
- SG10202000307VA SG10202000307VA SG10202000307VA SG10202000307VA SG10202000307VA SG 10202000307V A SG10202000307V A SG 10202000307VA SG 10202000307V A SG10202000307V A SG 10202000307VA SG 10202000307V A SG10202000307V A SG 10202000307VA SG 10202000307V A SG10202000307V A SG 10202000307VA
- Authority
- SG
- Singapore
- Prior art keywords
- materials
- methods relating
- silicate compositions
- polymeric silicate
- stabilised polymeric
- Prior art date
Links
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 title 1
- 239000000463 material Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
- C08G77/02—Polysilicates
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/34—Silicon-containing compounds
- C08K3/36—Silica
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L83/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon only; Compositions of derivatives of such polymers
- C08L83/02—Polysilicates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K2201/00—Specific properties of additives
- C08K2201/011—Nanostructured additives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polymers & Plastics (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Oncology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201402672A GB201402672D0 (en) | 2014-02-14 | 2014-02-14 | Materials and methods relating to stabilised polymeric silicate compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10202000307VA true SG10202000307VA (en) | 2020-03-30 |
Family
ID=50440204
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10202000307VA SG10202000307VA (en) | 2014-02-14 | 2015-02-13 | Materials and methods relating to stabilised polymeric silicate compositions |
| SG10202007920RA SG10202007920RA (en) | 2014-02-14 | 2015-02-13 | Materials and methods relating to stabilised polymeric silicate compositions |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10202007920RA SG10202007920RA (en) | 2014-02-14 | 2015-02-13 | Materials and methods relating to stabilised polymeric silicate compositions |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US20170042934A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3105281B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6618475B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102354909B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN106164136B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2015216711B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2939419C (cg-RX-API-DMAC7.html) |
| EA (1) | EA034577B1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2872498T3 (cg-RX-API-DMAC7.html) |
| GB (1) | GB201402672D0 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ723746A (cg-RX-API-DMAC7.html) |
| SG (2) | SG10202000307VA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2015121666A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3939599A3 (en) | 2007-10-15 | 2022-03-16 | HS Pharmaceuticals, LLC | Silicate containing compositions and methods of treatment |
| GB201507002D0 (en) * | 2015-04-24 | 2015-06-10 | Medical Res Council | Copper Oxo-hydroxide nanoparticles and their uses as biocidal agents |
| WO2017173317A1 (en) * | 2016-04-01 | 2017-10-05 | Nickels Daniel | Novel bone putty compositions and methods of use thereof |
| US10604257B2 (en) * | 2016-06-28 | 2020-03-31 | International Business Machines Corporation | Unmanned aerial vehicle for air sampling |
| US11007217B2 (en) | 2016-08-10 | 2021-05-18 | United Kingdom Research And Innovation | Compositions comprising nanosilica particles and their use in methods of activating T lymphocytes for therapy |
| KR20180034937A (ko) | 2016-09-28 | 2018-04-05 | 모멘티브퍼포먼스머티리얼스코리아 주식회사 | 유기 전자 소자 봉지재용 조성물 및 이를 이용하여 형성된 봉지재 |
| GB201701944D0 (en) * | 2017-02-06 | 2017-03-22 | Medical Res Council | Antimicrobial compositions and their uses |
| KR102427987B1 (ko) | 2018-11-27 | 2022-08-02 | 주식회사 엘지화학 | 전가수분해된 폴리실리케이트의 합성방법 |
| WO2020218834A1 (ko) * | 2019-04-24 | 2020-10-29 | 윤종오 | 카르복실산으로 유기화된 규소 이온 복합체 및 복합체의 제조방법과 이를 이용한 제품 |
| KR102207608B1 (ko) * | 2019-04-24 | 2021-01-26 | 윤종오 | 카르복실산으로 유기화된 규소 이온 복합체 및 복합체의 제조방법과 이를 이용한 제품 |
| AU2020405124A1 (en) * | 2019-12-20 | 2022-08-04 | Veri Nano Inc. | Nanostructured binary gel composition and use thereof |
| WO2025178550A1 (en) * | 2024-02-22 | 2025-08-28 | Lea Cares Ab | Method to form supernatant |
| SE2450523A1 (en) * | 2024-02-22 | 2025-08-23 | Lea Cares Ab | Method to form supernatant |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1688228A (en) | 1928-10-16 | gebmany | ||
| US4029770A (en) | 1974-03-26 | 1977-06-14 | Caw Industries, Inc. | Method of therapeutically treating damaged and/or infected tissue and relieving stress and shock in warm blooded animals |
| US4563351A (en) | 1983-08-01 | 1986-01-07 | Forsyth Dental Infirmary For Children | Self-gelling therapeutic compositions for topical application |
| US5080900A (en) | 1990-04-17 | 1992-01-14 | Stanley R Thomas | Treatment of skin ulcers with an aqueous extract of oak bark ash |
| HUT73791A (en) | 1992-11-06 | 1996-09-30 | H E Stanley Pharmaceuticals | Compositions of oak bark extract, related synthetic compositions, and method of using same |
| US7014870B1 (en) | 1992-11-06 | 2006-03-21 | Greystone Medical Group, Inc. | Compositions of oak bark extract related synthetic compositions and method of using same |
| US5370876A (en) | 1993-01-08 | 1994-12-06 | Microbarriers | Antimicrobial protective skin composition and method for protecting skin from body fluids |
| JP2588109B2 (ja) | 1993-03-19 | 1997-03-05 | 日本臓器製薬株式会社 | 鎮痛剤 |
| NL9400189A (nl) | 1994-02-07 | 1995-09-01 | Bio Pharma Sciences Bv | Gestabiliseerd orthosiliciumzuur bevattend preparaat, een werkwijze voor het bereiden daarvan en een biologisch preparaat. |
| US20060246154A1 (en) | 1997-10-08 | 2006-11-02 | Hon David N | Composition of oak bark extract, related synthetic compositions, and method of using same |
| FR2799758B1 (fr) | 1999-10-15 | 2002-05-17 | Exsymol Sa | Complexe a base d'acide orthosilicique biologiquement assimilable, se presentant sous forme solide, stable et concentree, et procede de preparation |
| CA2298762C (en) | 2000-02-11 | 2001-06-12 | Paul M. Pidcock | Therapeutic compositions consisting of clarified multi-filtered soluable sodium silicate in liquid form are found to modify suppressor cells and enhanse the human immune system toprevent recurrence of herpes infections |
| KR100330993B1 (ko) | 2000-02-18 | 2002-04-01 | 김승일 | 액상 사료 첨가제 및 이의 제조방법 |
| RU2182006C2 (ru) | 2000-03-01 | 2002-05-10 | Цивинский Станислав Викторович | Способ лечения ревматоидного артрита |
| US6692775B2 (en) | 2000-03-13 | 2004-02-17 | Aqua Med, Inc. | Bactericidal gel and method for treating burns and dermal lesions |
| US6288045B1 (en) | 2000-06-09 | 2001-09-11 | Lifelink Pharmaceuticals, Inc. | Epithelial cell cancer drug |
| KR100331952B1 (ko) | 2000-11-23 | 2002-04-09 | 최수일 | 다목적 고기능성 알칼리 용액 조성물 및 그 제조방법과 비특이 면역증강제로서의 용도 |
| US20040057958A1 (en) | 2002-05-17 | 2004-03-25 | Waggoner David W. | Immunogenicity-enhancing carriers and compositions thereof and methods of using the same |
| ATE361267T1 (de) | 2002-05-31 | 2007-05-15 | Sabalo N V | Wässrige lösung von nicht-kolloid-kieselsäure und borsäure |
| WO2004017913A2 (en) | 2002-08-22 | 2004-03-04 | Nutrition 21, Inc. | Arginine silicate inositol complex and use thereof |
| RU2237483C1 (ru) | 2003-02-21 | 2004-10-10 | Цивинский Станислав Викторович | Средство для лечения гастрита с повышенной кислотностью и язвенной болезни и способ их лечения |
| BR0318593A2 (pt) | 2003-05-15 | 2009-03-10 | Rahul Kanumuru Raju | silicatos de metais de transiÇço funcionais (ftms) |
| CN100366534C (zh) * | 2004-05-09 | 2008-02-06 | 中国石化北京燕化石油化工股份有限公司 | 适用于阴离子聚合的层状硅酸盐的改性方法、由此得到的改性层状硅酸盐及其用途 |
| CN1315484C (zh) | 2004-11-16 | 2007-05-16 | 关相龙 | 治疗皮肤病的药物载体组合物及制备方法 |
| RU2280458C1 (ru) | 2004-11-30 | 2006-07-27 | Алевтина Ивановна Косолапова | Противовоспалительная мазь |
| DE102004063599B4 (de) | 2004-12-30 | 2007-07-12 | Bayer Innovation Gmbh | Verkürzte Wundheilungsprozesse mittels neuartiger Faservliese |
| NZ537747A (en) | 2005-01-18 | 2008-02-29 | Victoria Link Ltd | Nano-structured silicate, functionalised forms thereof, preparation and uses |
| CA2604751A1 (en) | 2005-04-20 | 2006-12-28 | Laboratoires Mauves Inc. | Organic silicic acids complex for therapeutic and cosmetic applications |
| US20070161539A1 (en) * | 2006-01-12 | 2007-07-12 | Enrique Hernandez | Method of regulating degree of polymerization of an alkali metal silicate in solution using pH |
| CA2673313A1 (en) | 2006-12-18 | 2008-12-04 | Amcol International | Virus-interacting layered phyllosilicates and methods of use |
| US20100278935A1 (en) | 2007-07-30 | 2010-11-04 | Stacey William C | Immune System Modulator Formulation |
| EP3939599A3 (en) | 2007-10-15 | 2022-03-16 | HS Pharmaceuticals, LLC | Silicate containing compositions and methods of treatment |
| WO2009114087A2 (en) | 2008-03-03 | 2009-09-17 | Luna Innovations Incorporated | A method for treating pruritus by administering fullerenes |
| WO2009127256A1 (en) * | 2008-04-17 | 2009-10-22 | Jisbrey, S.A | Hydronium stabilized and dissoluble silicic acid nanoparticles: preparation, stabilization and use |
| EP2151466A1 (en) * | 2008-08-01 | 2010-02-10 | SiNatur GmbH | Biologically active silicic acid |
| EP2371220B2 (en) * | 2010-03-31 | 2018-01-17 | Taminco | Stabilized bio-available soluble silicate solution |
| CA2852210C (en) * | 2010-10-26 | 2019-04-02 | Quinnova Pharmaceuticals, Inc. | Composition and method for treating wounds |
| GB201402669D0 (en) * | 2014-02-14 | 2014-04-02 | Medical Res Council | Stabilised silicate compositions and their uses |
-
2014
- 2014-02-14 GB GB201402672A patent/GB201402672D0/en not_active Ceased
-
2015
- 2015-02-13 CN CN201580018382.3A patent/CN106164136B/zh active Active
- 2015-02-13 EA EA201691441A patent/EA034577B1/ru unknown
- 2015-02-13 EP EP15707169.7A patent/EP3105281B1/en active Active
- 2015-02-13 JP JP2016551833A patent/JP6618475B2/ja active Active
- 2015-02-13 WO PCT/GB2015/050409 patent/WO2015121666A1/en not_active Ceased
- 2015-02-13 CA CA2939419A patent/CA2939419C/en active Active
- 2015-02-13 NZ NZ723746A patent/NZ723746A/en unknown
- 2015-02-13 SG SG10202000307VA patent/SG10202000307VA/en unknown
- 2015-02-13 US US15/119,071 patent/US20170042934A1/en not_active Abandoned
- 2015-02-13 AU AU2015216711A patent/AU2015216711B2/en active Active
- 2015-02-13 KR KR1020167024827A patent/KR102354909B1/ko active Active
- 2015-02-13 ES ES15707169T patent/ES2872498T3/es active Active
- 2015-02-13 SG SG10202007920RA patent/SG10202007920RA/en unknown
-
2018
- 2018-10-24 US US16/169,437 patent/US10898511B2/en active Active
-
2020
- 2020-12-15 US US17/121,884 patent/US11833171B2/en active Active
-
2023
- 2023-10-27 US US18/495,938 patent/US20240066053A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20170042934A1 (en) | 2017-02-16 |
| US20210145866A1 (en) | 2021-05-20 |
| HK1226424A1 (zh) | 2017-09-29 |
| GB201402672D0 (en) | 2014-04-02 |
| KR102354909B1 (ko) | 2022-01-24 |
| CA2939419C (en) | 2022-07-26 |
| CA2939419A1 (en) | 2015-08-20 |
| JP6618475B2 (ja) | 2019-12-11 |
| EA201691441A1 (ru) | 2017-02-28 |
| SG10202007920RA (en) | 2020-10-29 |
| JP2017512189A (ja) | 2017-05-18 |
| NZ723746A (en) | 2022-09-30 |
| WO2015121666A1 (en) | 2015-08-20 |
| ES2872498T3 (es) | 2021-11-02 |
| US10898511B2 (en) | 2021-01-26 |
| CN106164136B (zh) | 2019-11-08 |
| EA034577B1 (ru) | 2020-02-21 |
| CN106164136A (zh) | 2016-11-23 |
| EP3105281B1 (en) | 2021-04-21 |
| US20190224233A1 (en) | 2019-07-25 |
| US11833171B2 (en) | 2023-12-05 |
| AU2015216711B2 (en) | 2018-08-09 |
| US20240066053A1 (en) | 2024-02-29 |
| AU2015216711A1 (en) | 2016-09-22 |
| EP3105281A1 (en) | 2016-12-21 |
| KR20160124797A (ko) | 2016-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10202007920RA (en) | Materials and methods relating to stabilised polymeric silicate compositions | |
| GB201402669D0 (en) | Stabilised silicate compositions and their uses | |
| IL249011B (en) | Methods and preparations related to exosomes | |
| GB2535253B (en) | Compositions and methods | |
| ZA201702213B (en) | Interleukin-15 compositions and uses thereof | |
| EP3177578A4 (en) | Carbonatable calcium silicate compositions and methods thereof | |
| IL250568B (en) | Anti-methanogenic preparations and their uses | |
| GB2537078B (en) | Settable compositions and uses thereof | |
| PL3122448T3 (pl) | Dyspersje zawierające kapsułkowany materiał i kompozycje z ich zastosowaniem | |
| GB2546650B (en) | Lime-based cement composition | |
| PT3102555T (pt) | Composições de compostos e seus usos | |
| SG11201608866WA (en) | Asphalt composition | |
| SG11201609760XA (en) | Asphalt composition | |
| PL3148517T3 (pl) | Kompozycje i sposoby do promowania tworzenia kości | |
| PL3169642T3 (pl) | Sucha mieszanka cementowa | |
| ZA201702488B (en) | Improvements in or relating to connecting devices | |
| IL251238B (en) | Mineral-based compounds and their uses | |
| GB201504683D0 (en) | Improvements in or relating to manufacture of packing | |
| GB201416463D0 (en) | Improvements in or relating to temporary structures | |
| GB201407855D0 (en) | Improved concrete mix | |
| GB201402915D0 (en) | Compositions and methods | |
| GB201504361D0 (en) | Fluorocarbon-substituted carboranes as energtic materials | |
| GB201402085D0 (en) | Improvements in and relating to jointing compounds | |
| GB201402180D0 (en) | Improvements in or relating to tiles | |
| SG11201703853QA (en) | Composition comprising particles |